Evidence map›Paper›PMID 40046173›Full record

ReviewJournal of asthma and allergy2025

The Role of Ubiquitin-Proteasome System (UPS) in Asthma Pathology.

Shuzhou Deng, Le Ding, Yisong Qian, Xuan Huang

Abstract readReview
In one paragraph

Review in Journal of asthma and allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. E3 ubiquitin ligases and asthma relief.American journal of respiratory cell and molecular biology · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuzhou DengThe National Engineering Research Center for Bioengineering Drugs and the Technologies, Jiangxi Provincial Laboratory of Bioengineering Drugs, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
Le DingThe National Engineering Research Center for Bioengineering Drugs and the Technologies, Jiangxi Provincial Laboratory of Bioengineering Drugs, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
Yisong QianThe National Engineering Research Center for Bioengineering Drugs and the Technologies, Jiangxi Provincial Laboratory of Bioengineering Drugs, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.ORCID 0000-0001-6251-6756
Xuan HuangThe National Engineering Research Center for Bioengineering Drugs and the Technologies, Jiangxi Provincial Laboratory of Bioengineering Drugs, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.ORCID 0000-0002-9708-2270

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma represents a major global health concern, underscoring an imperative for further exploration into its pathogenesis to inform the development of more effective treatment strategies. As a key mechanism for intracellular protein degradation and regulation, the ubiquitin-proteasome system (UPS) plays a crucial but complex and multifaceted role in the pathological process of asthma. This study systematically reviews the functions and mechanisms of E3 ubiquitin ligases and deubiquitinases within the UPS in asthma. The study explores the impact of these mechanisms on the occurrence of inflammation and the alteration of airway hyperresponsiveness by regulating the synthesis and release of inflammatory factors, as well as the proliferation or differentiation of key inflammatory cells. A comprehensive understanding of the pathological mechanism of UPS in asthma will help to provide new theoretical basis and potential drug targets for the precision treatment, which holds great promise for the treatment of asthma in the future.

Indexed as

asthmadeubiquitinasesE3 ubiquitin ligaseUPS

Identifiers

PMID40046173
PMCPMC11881607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.